C6ORF211 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.16637818795107E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.28840002292463E-09 |
Normal-vs-Stage2 |
2.438900E-03 |
Normal-vs-Stage3 |
3.08049999953042E-07 |
Normal-vs-Stage4 |
2.88650003898994E-09 |
Stage1-vs-Stage2 |
8.532800E-01 |
Stage1-vs-Stage3 |
4.242200E-01 |
Stage1-vs-Stage4 |
1.302810E-01 |
Stage2-vs-Stage3 |
7.512200E-01 |
Stage2-vs-Stage4 |
4.189200E-01 |
Stage3-vs-Stage4 |
4.924400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.67694763525606E-12 |
Normal-vs-AfricanAmerican |
9.7990999999964E-05 |
Normal-vs-Asian |
7.343200E-01 |
Caucasian-vs-AfricanAmerican |
7.892000E-01 |
Caucasian-vs-Asian |
2.333600E-01 |
AfricanAmerican-vs-Asian |
2.154400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.77113879118451E-12 |
Normal-vs-Female |
1.83602999999088E-05 |
Male-vs-Female |
8.564000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.173400E-04 |
Normal-vs-Age(41-60Yrs) |
1.79589999982355E-07 |
Normal-vs-Age(61-80Yrs) |
2.31950014750737E-11 |
Normal-vs-Age(81-100Yrs) |
1.23500000226429E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.703000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.895200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.840400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.432800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.123800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.792620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.355600E-01 |
Normal-vs-Grade 2 |
1.72779999999539E-05 |
Normal-vs-Grade 3 |
6.48148201776166E-12 |
Normal-vs-Grade 4 |
1.80300219199125E-13 |
Grade 1-vs-Grade 2 |
5.400000E-01 |
Grade 1-vs-Grade 3 |
1.224170E-01 |
Grade 1-vs-Grade 4 |
7.248100E-02 |
Grade 2-vs-Grade 3 |
1.584990E-01 |
Grade 2-vs-Grade 4 |
1.279910E-03 |
Grade 3-vs-Grade 4 |
2.044300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.425500E-04 |
Normal-vs-ccB subtype |
4.54389859072535E-11 |
ccA subtype-vs-ccB subtype |
5.237700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.07510000188793E-08 |
Normal-vs-N1 |
2.543900E-02 |
N0-vs-N1 |
5.117200E-01 |
|
|